A NSW Government website

Addressing the disruptions caused by COVID-19

Investment NSW

Forty two small and medium enterprises obtained $25,000 to $50,000 support funding to commercialise a product or service that addresses the health, wellbeing and/or economic impacts of COVID-19.

The COVID-19 TechVoucher program provided support funding for technology-rich startups, scaleups or small and medium enterprises (SMEs) to collaborate with Publicly Funded Research Organisations (PFROs).

Successful applicants could accelerate the commercialisation of innovative R&D products and services that address the many health and economic disruptions caused by the COVID-19 pandemic.

Activities that were funded by TechVouchers included:

  • access to research facilities and equipment such as electron microscopes, medical imaging, and other PRFO delivery partner facilities
  • product or process design, such as engineering or technical design expertise to determine prototype structure, function or materials
  • validating or demonstrating technical capabilities of a product, process or technology including clinical trials and in-market validation
  • funding toxicology studies on materials that could be incorporated into a new product
  • testing and certification for supply of products
  • enhancing existing product capabilities or enabling entry to international markets.

More news from Investment NSW

NSW’s most outstanding international students, education providers, businesses and community groups have this week been named and celebrated at the state’s most prestigious international education awards.
Trade leaders from all States and Territories gathered in Sydney today to discuss pressing issues and deepen Australia’s collaborative approach to trade and investment priorities locally and internationally.
The NSW Innovation and Productivity Council has outlined a set of recommendations to gain more value from the state’s thriving innovation sector and to better measure the effectiveness of government support.